[PDF][PDF] Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate.

DE Mager, ER Cox - American Journal of Managed Care, 2007 - researchgate.net
Objective: To evaluate the relationship between generic and brand copayment differentials
and generic fill rate (GFR). Study Design: Cross-sectional. Methods: Aggregate-level retail …

Differences in prescription drug use in HMO and self-insured health plans

SS Wallack, CP Thomas, TC Martin… - Medical care research …, 2007 - journals.sagepub.com
Using pharmacy benefits manager claims data, this study analyzed how cost-management
techniques including cost sharing affected enrollees in health maintenance organizations …

Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans

MA Fischer, J Avorn - Health services research, 2003 - Wiley Online Library
Objective. To calculate the financial impact of underuse of generic medications in state
Medicaid programs. Data Sources/Study Setting. State‐by‐state data on Medicaid drug …

Effects of an increase in prescription copayment on utilization of low-sedating antihistamines and nasal steroids

BL Meissner, WM Moore, JA Shinogle… - Journal of Managed …, 2004 - jmcp.org
BACKGROUND: Health plans are using 3-tier copayment designs and other methods to
control utilization that shifts drug costs to plan members. There is a need to determine the …

[HTML][HTML] Cost Control for Prescription Drug Programs: Pharmacy Benefit Manager PBM Efforts, Effects, and Implications

DH Kreling - Department of Health and Human Services Conference …, 2000 - aspe.hhs.gov
With increased attention focused on prescription drug programs, expenditures, and
coverage, interest also has increased in drug program cost control measures, in particular …

Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs

P Nemlekar, M Shepherd, K Lawson… - Journal of Managed Care …, 2013 - jmcp.org
BACKGROUND: Promotion of prescription drug coupons and vouchers by pharmaceutical
manufacturers has increased in recent years. These coupons and vouchers usually …

Prescription drug cost sharing: associations with medication and medical utilization and spending and health

DP Goldman, GF Joyce, Y Zheng - Jama, 2007 - jamanetwork.com
ContextPrescription drugs are instrumental to managing and preventing chronic disease.
Recent changes in US prescription drug cost sharing could affect access to them …

[HTML][HTML] Impacts of generic competition and benefit management practices on spending for prescription drugs: evidence from Medicare's Part D benefit

S Sheingold, NX Nguyen - Medicare & Medicaid Research Review, 2014 - ncbi.nlm.nih.gov
Impacts of Generic Competition and Benefit Management Practices on Spending for
Prescription Drugs: Evidence from Medicare’s Part D Benefit - PMC Back to Top Skip to …

Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan.

KV Nair, F Frech-Tamas, S Jan, P Wolfe… - Journal of health care …, 2011 - europepmc.org
Objective To examine the impact of the coverage gap on pharmacy use, expenditures, and
out-of-pocket costs for Medicare managed care beneficiaries before and after reaching the …

Spillover effects of restrictive drug formularies on physician prescribing behavior: Evidence from medicaid

YR Wang, MV Pauly - Journal of Economics & Management …, 2005 - Wiley Online Library
Restrictive drug formularies may influence physician prescribing behavior for other patients
with more generous drug benefit, so‐called “spillover effects.” We focus on Protonix, a …